Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Iran Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... The market is expected to reach 1.3 billion in five years, registering a CAGR of more than 4.3% during the forecast period. Inadequate precautions that disrupt traditional patient relationships, drug shortages, disruptions to routine diabetes ... Read More
-
New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The ... Read More
-
New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients ... Read More
-
Japan Insulin Drugs and Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029). The number of Japanese victims during the COVID-19 pandemic was lower than in ... Read More
-
Egypt Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... year to USD 442 million by the forecast year, registering a CAGR of 3.36% during the forecast period. The COVID-19 pandemic positively impacted Egypt's diabetes care devices market growth. Patients with diabetes infected with COVID-19 ... Read More
-
Malaysia Insulin Infusion Pump - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 0.92 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). According to the Agency for Clinical Research (ICR), a research agency affiliated with the National Institutes of ... Read More
-
Middle East and Africa Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... million in 2024, and is expected to reach USD 50.85 million by 2029, growing at a CAGR of 4.80% during the forecast period (2024-2029). The COVID-19 pandemic positively impacted the growth of the insulin infusion ... Read More
-
South Korea Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... is expected to reach USD 529.86 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029). The COVID-19 pandemic has substantially impacted the diabetes care devices market. The prevalence of diabetes ... Read More
-
South Korea Insulin Infusion Pump - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 21.88 million by 2029, growing at a CAGR of 4.02% during the forecast period (2024-2029). Diabetes patients are more prone to experience complications if they become infected with a virus. ... Read More
-
South Korea Insulin Drugs And Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... of 1.5% and reach a value of about USD 795 million over the forecast period. One of the most significant risk factors for severe COVID-19 was diabetes mellitus. This risk is believed to be influenced ... Read More
-
Endocrinology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... impacted the endocrinology drugs market since many research studies demonstrated that people with thyroid disorders and diabetes are more prone to COVID-19 infection, creating a significant demand for the appropriate use of various endocrine drugs. ... Read More
-
Philippines Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... The market is expected to reach USD 0.4 billion in five years, registering a CAGR of more than 4% during the forecast period. COVID-19 is a new disease caused by the SARS-CoV-2 virus strain. Most ... Read More
-
New Zealand Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and ... Read More
-
New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If ... Read More
-
Global Contract Development and Manufacturing Organization (CDMO) Market: Analysis By Type (Chemical Drugs & Biologics), By Product (API/Bulk Drugs Drug Product Manufacturing (Inc. Dosage & Formulation Development) & Packaging), By Sourcing (In House & Outsourced), By Application (Oncology, Cardiovascular Disease, Diabetes, Hormonal, Glaucoma & Others), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Application (Oncology, Cardiovascular Disease, Diabetes, Hormonal, Glaucoma & Others), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029 The global contract development and manufacturing organization (CDMO) market was valued ... Read More
-
Global Insulin Pen Market
... based on the type, duration, end user and region. Report Includes: An overview of the global market for insulin pen Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of ... Read More
-
2024 Global: Medicaments Containing Insulin But Not Antibiotics, For Therapeutic Or Prophylactic Uses, Put Up In Measured Doses Or For Retail Sale Products-Manufacturing Forecast (2030) report
... For Therapeutic Or Prophylactic Uses, Put Up In Measured Doses Or For Retail Sale Products-Manufacturing Forecast (2030) report analyzies the market size, projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' ... Read More
-
2024 Global Pharmaceutical Preparations, Affecting Neoplasms, The Endocrine System, And Metabolic Diseases, For Human Use Products Markets (2030 Outlook)
... Products Markets (2030 Outlook) report features market size data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), ... Read More
-
Philippines Diabetes Care Devices Market Report and Forecast 2024-2032
... at a CAGR of 7.6 % during the forecast period of 2024-2032, driven increasing incidence of diabetes among the population and awareness initiatives to detect the condition early. Diabetes Care Devices: Introduction Diabetes care devices ... Read More
-
Wearable Injectors Market by Type(On-body, Off-body), Technology (Spring, Motor Drive, Expanding Battery, Rotary Pump), Indications (Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain), End Users (Hospital & Clinic, Homecare) - Global Forecast to 2029
... injectors market is projected to reach USD 15.1 billion by 2029 from USD 8.4 billion in 2023, at a CAGR of 10.3% during the forecast period. Precise, user-friendly design, efficient delivery of large molecules, favorable ... Read More
-
Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet's Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 ... Read More
-
Saudi Arabia In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], Opportunities and Forecast, 2016-2030F
... Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], Opportunities and Forecast, 2016-2030F Saudi Arabia in-vitro diagnostics market is projected ... Read More
-
Canada In-vitro Diagnostics Market Assessment, By Product [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Home Care Settings, Others], By End-users [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Home Care Settings, Others], By End-users [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2017-2031F Canada in-vitro diagnostics ... Read More
-
Global In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Global In-vitro diagnostics market is projected to ... Read More
-
North America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The North America bioanalytical testing services market was valued ... Read More
Research Assistance
